Skip to main content
. 2021 Jul 23:91–144. doi: 10.1016/B978-0-323-90595-4.00002-9

Table 5.1.

Lines of Treatment for Covid-19.

  • 1.

    Antiviral drugs (remdesivir, lopinavir/ritonavir combination, umifenovir, and favipiravir)

  • 2.

    Antibacterial drugs

  • 3.

    Antimalarial drugs

  • 4.

    Antiparasitics

  • 5.

    Anticoagulants

  • 6.
    Immune-based therapy
    • a.
      Immunomodulatory therapy
      • i.
        Steroids
      • ii.
        Interleukin inhibitors
      • iii.
        Interferons
    • b.
      Human blood-derived products
      • i.
        Convalescent plasma
      • ii.
        Immunoglobulins
      • iii.
        Mesenchymal stem cells
  • 7.
    Host-directed therapy
    • a.
      Metformin
    • b.
      Statins
    • c.
      Pioglitazones
  • 8.
    Other therapeutic agents
    • a.
      Angiotensin-converting enzyme inhibitors
    • b.
      Nonsteroidal antiinflammatory drugs
    • c.
      Vitamin C
    • d.
      Vitamin D
    • e.
      Zinc
    • f.
      lactoferrin
    • g.
      Melatonin
  • 9.

    Oxygen therapy